Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, China.
The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Medicine (Baltimore). 2024 May 31;103(22):e38388. doi: 10.1097/MD.0000000000038388.
The aim of this study was to provide comprehensive and reliable evidence for the treatment of pain and motor function in patients with frozen shoulder (FS) with hydrodistension.
The research including randomized controlled trials (RCTs) for FS that compared hydrodistension with routine treatments to controls was searched and screened in the PubMed, Library of congress, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, China Science and Technology Journal Database. Constant-Murley score (CMS) for shoulder function and visual analog scale (VAS) for pain must be assessed. RevMan 5.3 software was used to evaluate the bias and quality of the included studies.
We found that analgesic effects (MD: -1.07; 95% CI: -1.94 to -0.20; P < .00001; I2 = 99%) and function (MD: 8.54; 95% CI: 3.35 to 13.71; P < .00001; I2 = 97%) were better in the groups where hydrodistension plus routine treatments were used to treat FS compared to other interventions.
The result suggests that hydrodistension is of great clinical significance in alleviating pain and improving function to patients with FS.
本研究旨在为水扩张治疗冻结肩（FS）患者的疼痛和运动功能提供全面可靠的证据。
我们在 PubMed、美国国会图书馆、 Cochrane 图书馆、Web of Science、中国知网（CNKI）、万方数据知识服务平台和中国科技期刊数据库中搜索并筛选了比较水扩张与常规治疗对对照组的 FS 的随机对照试验（RCT）。必须评估肩部功能的Constant-Murley 评分（CMS）和疼痛的视觉模拟评分（VAS）。使用 RevMan 5.3 软件评估纳入研究的偏倚和质量。
我们发现与其他干预措施相比，水扩张联合常规治疗治疗 FS 的镇痛效果（MD：-1.07；95%CI：-1.94 至-0.20；P<0.00001；I2=99%）和功能（MD：8.54；95%CI：3.35 至 13.71；P<0.00001；I2=97%）更好。
结果表明，水扩张在缓解 FS 患者疼痛和改善功能方面具有重要的临床意义。
